SCHEMBL7965668

SCHEMBL7965668

CCC(CCC(C#N)(c1ccc(Cl)cc1)C(C)C)N(C)C(C)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EBP Q15125 2/20 0.43
SIGMAR1 Q99720 2/20 0.43
CYP3A4 P08684 6/20 0.35
CYP2D6 P10635 4/20 0.35
BCL2 P10415 1/20 0.33
CNR1 P21554 4/20 0.33
CNR2 P34972 2/20 0.33
UTS2R Q9UKP6 2/20 0.32
ABCB1 P08183 3/20 0.32
ABCC1 P33527 3/20 0.32
CYP2C19 P33261 2/20 0.32
SLC6A4 P31645 2/20 0.32
DRD2 P14416 2/20 0.32
OPRM1 P35372 2/20 0.32
DRD3 P35462 2/20 0.32
MEN1 O00255 2/20 0.32
ABCB11 O95342 2/20 0.32
KMT2A Q03164 2/20 0.32
KCNH2 Q12809 2/20 0.32
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7968976 0.91 EBP (0.41) EBPSIGMAR1CYP3A4CYP2D6BCL2
SCHEMBL7968647 0.89 EBP (0.43) EBPSIGMAR1CYP3A4CYP2D6ABCB1
SCHEMBL7971946 0.89 EBP (0.43) EBPSIGMAR1CYP3A4CYP2D6ABCB1
SCHEMBL7965756 0.89 EBP (0.43) EBPSIGMAR1CYP3A4CYP2D6CYP2C19
SCHEMBL7965708 0.88 EBP (0.39) EBPSIGMAR1CYP3A4CYP2D6ABCB1
SCHEMBL7968615 0.87 EBP (0.46) EBPSIGMAR1CYP3A4CYP2D6BCL2
SCHEMBL7968651 0.86 EBP (0.39) EBPSIGMAR1CYP3A4CYP2D6ABCB1
SCHEMBL7969091 0.84 SIGMAR1 (0.47) EBPSIGMAR1CYP3A4CYP2D6BCL2
SCHEMBL7968732 0.84 L3MBTL1 (0.38) EBPSIGMAR1CYP3A4CYP2D6KCNH2
SCHEMBL7955944 0.84 EBP (0.36) EBPSIGMAR1CYP3A4CYP2D6AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6265439-B1 Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives G.D. SEARLE & CO. 2001-07-24 US disclosed